Skip to main content

Legend Biotech Corporation (LEGN) Stock

Legend Biotech Corporation Stock Details, Movements and Public Alerts

Stock Details

Legend Biotech Corporation (LEGN), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NMS.Currently, the stock is trading at $19.27. Over the past 52 weeks, it has ranged between $16.24 and $37.50. This places the current price at 51.4% of its 52-week high and 18.7% above its 52-week low. Recent trading volume was recorded at 979,577. The 14-day Relative Strength Index (RSI) stands at 52.09, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $19.52 by 1.28%. Similarly, it is below its 200-day moving average of $22.17 by 13.08%. The MACD histogram is 0.11, indicating bullish momentum (MACD Line: -0.12, Signal Line: -0.24). There are currently 5 active alerts set for LEGN by users.

52-Week Range

$37.50 - $16.24

-48.61% from high · +18.66% from low

Avg Daily Volume

1,977,305

20-day average

100-day avg: 2,362,307

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

18.35

Price to Book

3.04

EV/EBITDA

-73.26

EPS (TTM)

-$0.52

Price to Sales

2.95

Beta

0.57

Less volatile than market

Q:How is LEGN valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is LEGN's risk profile compared to the market?
With a beta of 0.57, Legend Biotech Corporation is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 3.04 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-7.20%

Operating Margin

14.89%

EBITDA

$-41,600,000

Return on Equity

-8.08%

Return on Assets

-1.92%

Revenue Growth (YoY)

51.90%

Q:How profitable and efficient is LEGN's business model?
Legend Biotech Corporation achieves a profit margin of -7.20%, meaning it retains $-7.20 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 14.89% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -8.08% and ROA at -1.92%, the company achieves moderate returns on invested capital.
Q:What are LEGN's recent growth trends?
Legend Biotech Corporation's revenue grew by 51.90% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. These growth metrics should be evaluated against Biotechnology industry averages for proper context.

Company Size & Market

Market Cap

$3.7B

Revenue (TTM)

$1.27B

Revenue/Share (TTM)

$6.86

Shares Outstanding

194.49M

Book Value/Share

$6.35

Asset Type

EQUITY

Q:What is LEGN's market capitalization and position?
Legend Biotech Corporation has a market capitalization of $3.7B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 194.49M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does LEGN's price compare to its book value?
Legend Biotech Corporation's book value per share is $6.35, while the current stock price is $19.27, resulting in a price-to-book (P/B) ratio of 3.04. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$45.62

136.75% upside potential

Analyst Recommendations

Strong Buy

5

Buy

6

Hold

4

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for LEGN?
15 analysts cover LEGN with 73% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $45.62 implies 136.8% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on LEGN?
Current analyst recommendations:5 Strong Buy, 6 Buy, 4 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Oct 24, 2026, 02:17 AM

Technical Indicators

RSI (14-day)

52.09

Neutral

50-Day Moving Average

$19.52

-1.28% below MA-50

200-Day Moving Average

$22.17

-13.08% below MA-200

MACD Line

-0.12

MACD Signal

-0.24

MACD Histogram

0.11

Bullish

Q:What does LEGN's RSI value tell investors?
The RSI (Relative Strength Index) for LEGN is currently 52.09, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret LEGN's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.12 above the signal line at -0.24, with histogram at 0.11. This bullish crossover suggests upward momentum is building. The 50-day MA ($19.52) is below the 200-day MA ($22.17), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Oct 24, 2026, 12:56 AM

Active Alerts

Alert Condition
Price rises above
Threshold
$27.00
Created
Aug 29, 2026, 12:11 PM
Alert Condition
Price rises above
Threshold
$27.00
Created
Aug 29, 2026, 12:02 PM
Alert Condition
Price rises above
Threshold
$27.00
Created
Aug 13, 2026, 03:39 PM
Alert Condition
Price falls below
Threshold
$15.75
Created
Aug 13, 2026, 03:39 PM
Alert Condition
Price falls below
Threshold
$15.75
Created
Aug 13, 2026, 03:15 PM

Stay Ahead of the Market with Legend Biotech Corporation Alerts

Set up price alerts for Legend Biotech Corporation and get notified instantly when the price hits your target. Never miss an important price movement again.